ITHBĀT ʿANĀṢIR AL-MASʾŪLIYYAH AL-MADANIYYAH FĪ MUNĀZAʿĀT AL-ADWIYAH: DIRĀSAH MUQĀRINAH

Authors

  • Nour Eddine LKAMEL Université Sidi Mohamed Ben Abdellah, Fez
  • Mohammed SEMNOUN Université Sidi Mohamed Ben Abdellah, Fez

DOI:

https://doi.org/10.30863/aldustur.v9i2.11450

Keywords:

Proof., Fault, Defect, Damage, Causation, Pharmaceuticals

Abstract

In the legal field, proof plays a fundamental role in ensuring justice and strengthening legal security, as it serves as the means to uncover the truths of facts and present evidence before competent judicial authorities to support or refute claims. Its importance becomes even greater when it concerns proving the conditions for civil liability in pharmaceutical cases, which are both legally and technically complex. Despite significant advancements in legislation aimed at protecting pharmaceutical users, substantial challenges remain in proving fault, defects, causation, and damages due to the technical complexity of pharmaceutical products. This study highlights these challenges and evaluates the adequacy of the current legal framework, focusing on the Moroccan context and comparing it to the French and American legal systems. By adopting a comparative analytical approach that examines legal texts and judicial positions, the study concludes that the current legal rules suffer from significant shortcomings in addressing pharmaceutical cases. It calls for improving evidentiary mechanisms, such as adopting presumed liability and shifting the burden of proof in favor of affected pharmaceutical users. Furthermore, the study proposes enacting specific legal provisions to facilitate the establishment of civil liability, enhancing the judiciary's role in adopting flexible judicial presumptions, implementing comprehensive documentation systems to ensure transparency in all stages of pharmaceutical production and distribution, and launching awareness campaigns to empower affected pharmaceutical users to understand and claim their legal rights.

References

ABC News. “Strange Side Effects Surprise Patients.” ABC News, February 11, 2009. https://abcnews.go.com/Health/story?id=5374153&page=1.

Abdul Ghafar, Anas Mohammed. Al-Mas’uliyya Al-Madaniyya Fi Al-Majal Al-Tibbi – Dirasat Muqarana Bayn Al-Qanun Wal-Shari’a Al-Islamiya. Dar Al-Kutub Al-Qanuniya, 2010.

Al-Adnani, Al-Azzawi. “Mas’uliyat Al-Dawla ’An Al-Adrar Al-Natija ’An Jaihat Virus Korona – COVID-19.” Moroccan Journal of Local Administration and Development Silsilat Mawakib Al-Sa’a, Al-Qanun Fi Mahak Halat Al-Tawari’ Al-Sihhiya Bisebab Al-Virus Al-Taji COVID-19, no. 112 (2021): 557–76.

Al-Ashmawi, Ayman Ibrahim. Tatawwur Mafhoom Al-Khata’ Ka Asas Lil-Mas’uliyya Al-Madaniyya. Dar Al-Nahda Al-Arabiya, 1998.

Al-Ghasham Al-Sha’ibi, Al-Mustafa. Al-Aqd Al-Tibbi. 1st ed. Dar Al-Salam Lil-Tiba’a Wal-Nashr Wal-Tawzi’a, 2016.

Al-Kazbari, Ma’moun. Nadhariyat Al-Iltizamat Fi Dhu’ Qanun Al-Iltizamat Wal-Uqud Al-Maghribi – Masadir Al-Iltizamat. 2nd ed. First. Dar Al-Qalam, 1974.

Al-Ni’ma, Youssef Ahmed Hussein. Daf’ Al-Mas’uliyya Al-Madaniyya Bikhata’ Al-Madhurur – Dirasat Muqarana. Dar Al-Ta’lif, 1991.

Al-Qutb, Mohammed Mohammed. Al-Mas’uliyya Al-Madaniyya Al-Nash’iya “An Adrar Al-Dawa”, Mashakilaha Wa Khasosiyat Ahkamaha. Dar Al-Jamia’ Al-Jadida, 2014.

Al-Safi, Abdul Rahman. “Islah Muassassat Al-Mas’uliyya Al-Madaniyya Fi Dhu’ Al-Tahawulat Al-Qanuniyya Wal-Iqtisadiyya Wal-Ijtima’iyya Al-Mu’asira.” Doctoral Thesis in Private Law, Faculty of Legal, Economic and Social Sciences, Sidi Mohamed Ben Abdallah University, 2020.

Al-Sanhouri, Abdulrazak Ahmed. Al-Wasit Fi Sharh Al-Qanun Al-Madani, Nadhariyat Al-Iltizam Bi-Wajh “Aam, Al-Aqd – Al-’Amal Ghayr Al-Mashrou” – Al-Ithra’ Bila Sabab – Al-Qanun. Vol. 1. Dar Ihya’ Al-Turath Al-Arabi, 1964.

Al-Shami, Mohammed Hussein Ali. “The Element of Fault in Civil Liability, a Comparative Study between Egyptian and Yemeni Civil Law and Islamic Jurisprudence.” Thesis for the degree of Doctor of Law, Kulliyat Al-Huquq, Jami’at Ain Shams, 1989.

Al-Yamouri, Farida. Alaqat Al-Sababiyya Fi Majal Al-Mas’uliyya Al-Taqsiriya Bayn Ra’y Al-Fiqh Wa Mawaqif Al-Qada’ (Dirasat Muqarana). 1st ed. Modern Legal Studies Series 16. Matba’at Al-Najah Al-Jadida, 2009.

Al-Zouind Vs Al-Dawla Al-Maghribiya, 28 Supreme Council Judicial Journal 2 (Supreme Council 1979).

Amer, Hussein, and Abdulrahim Amer. Al-Mas’uliyya Al-Madaniyya, Al-Taqsiriya Wal-Aqdiyya. 2nd ed. Dar Al-Ma’arif, 1979.

ASBIHI, Amine. “New Features of Civil Liability Pillars in Pharmaceutical Products.” In Legislative Orientations of Liability Systems in Light of Recent Developments, 1st ed. Al Maarifa Publishing House, 2018.

Bakkouch, Amal. Nahw Mas’uliyya Mawdu’iyya ’An Al-Tabi’at Al-Tibbiya, Dirasat Fi Al-Qanun Al-Jaza’iri Wal-Muqaran. Dar Al-Jamia’ Al-Jadida, 2011.

Barbeesh, AbdulLatif. “Ta’ammulat Fi Mawdou’ Al-Dawa.” Al-Akademiya Majallat Akademiyat Al-Mamlaka Al-Maghribiya, no. 22 (2005): 15–29.

Belhaj, Al-Arabi. Ahkam Al-Tajareb Al-Tibbiya “Ala Al-Insan Fi Dhu” Al-Shari’a Wal-Qawanin Al-Tibbiya Al-Mu’asira, Dirasat Muqarana. 1st ed. Dar Al-Thaqafah, 2012.

Boudyan Vs Africa Gaz, 145 Majallat Al-Mahakim Al-Maghribiya 100 (Supreme Council 2011). 2014.

Case N° 05/94/12 T, 1–1999 Mas’ouliyat Marafiq As-Siha Al-’Umoumiya 99 (Administrative Court of Meknes (Compensation Division) 1995).

Case N° 899_90, 1 Musannaf Al-Mas’uliyya Al-Tibbiya _ Hisilat Al-’Amal Al-Qada’i Fi Mawdou’ Al-Mas’uliyya Al-Madaniyya Lil-Atiba’ Wal-Misahat Al-Khasa ___ (Marrakech Court of First Instance 1992).

Case N°. 21887/2006, No. 262/13 (Supreme Council April 8, 2009). bit.ly/3hWQqMI.

Cham, Stephanie, Hayley J. Koslik, and Beatrice A. Golomb. “Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series.” Drug Safety - Case Reports 3, no. 1 (2016): 1. https://doi.org/10.1007/s40800-015-0024-2.

Commercial Case N°. 1059/3/1/2004, 490 bis (Supreme Council April 27, 2005). bit.ly/3tLs7H7.

Commission of the European Communities v United Kingdom of Great Britain and Northern Ireland, Case C-300/95 (ECJ May 29, 1997). https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A61995CJ0300.

Cour d’appel de Limoges, 18 Juin 2014, 13/00806, No. 13/00806 (Cour d’appel de Limoges June 18, 2014). https://www.legifrance.gouv.fr/juri/id/JURITEXT000029120130.

Cour de Cassation, Chambre Civile 1, Publié au bulletin ___ (Cour de cassation 2009). https://www.legifrance.gouv.fr/juri/id/JURITEXT000021078923?isSuggest=true.

Cour de Cassation, Chambre Civile 1, Publié au bulletin ___ (Cour de cassation 2009). https://www.legifrance.gouv.fr/juri/id/JURITEXT000021078971?isSuggest=true.

Cour de Cassation, Chambre Civile 1, Publié au bulletin ___ (Cour de cassation 2019). https://www.legifrance.gouv.fr/juri/id/JURITEXT000038708713?isSuggest=true.

D.A. Vs Smith Kline Beecham, 244 J.A/04 (Casablanca Court of First Instance November 7, 2005).

Decree N°. 2.14.841 Authorising the Placing on the Market of Medicines Intended for Human Use, Pub. L. No. 2.14.841 (2015). https://www.sante.gov.ma/sites/Ar/reglementation/DocLib7/2.14.841.pdf.

Easter v. Aventis Pasteur, Inc., CIV.A. 5:03-CV-141 (United States District Court, E.D. Texas. Texarkana Division February 14, 2005). https://casetext.com/case/easter-v-aventis-pasteur?fbclid=IwAR3isZDD8aItkIRUzTZ8G6_qNVifmBT4qUdijOhH1BUgbYE00yGH-yz-cSM.

El Rifai, Ahmed Mohamed. The Impact of the Victim’s Predisposition on the Defendant’s Liability. Dar Al-Nahda Al-Arabiya, 1996.

Fouassier, Éric. “Les Fondements Juridiques de La Responsabilité Du Producteur de Spécialités Pharmaceutiques: Vers Un Retour à La Raison?” Médecine & Droit 2006, no. 78 (2006): 103–9. https://doi.org/10.1016/j.meddro.2006.04.001.

Gorvett, Zaria. “The Medications That Change Who We Are.” News site. BBC, January 8, 2020. https://www.bbc.com/future/article/20200108-the-medications-that-change-who-we-are.

Jomaii, Hassan Abdulbasit. Mas’uliyat Al-Montij ’An Al-Adrar Al-Lati Tasabbabuha Muntajatuhu Al-Ma’yiba “Dirasat Muqarana Fi Dhu’ Tatawwur Al-Qada’ Al-Faransi Wa Sodor Al-Qanun Al-Faransi Bishaan Mas’uliyat Al-Montij 'An ‘Uyub Al-Mabi’ Fi 19 Mayo 1998.” Dar Al-Nahda Al-Arabiya, 2000.

Jourdain, Patrice. “Une Nouvelle Présomption de Causalité, Au Profit Cette Fois Des Victimes Du DES Ou Distilbène.” RTDCiv. Revue Trimestrielle de Droit Civil, no. 01 (2010): 111.

Kaye, David. “Probability Theory Meets Res Ipsa Loquitur.” Michigan Law Review 77, no. 6 (1979): 1456–84. https://doi.org/10.2307/1288109.

Kelley v. American Heyer-Schulte Corp., SA-93-CA-0145 (United States District Court, W.D. Texas, San Antonio Division March 11, 1997). https://casetext.com/case/kelley-v-american-heyer-schulte-corp#p880.

Kiely, Terrence F., and Bruce L. Ottley. “Understanding Products Liability Law.” SSRN Scholarly Paper No. 1327927. Social Science Research Network, April 1, 2006. https://papers.ssrn.com/abstract=1327927.

Le Monde, AFP. Rendu accro au jeu et au sexe par un médicament, un Nantais obtient réparation. March 31, 2011. https://www.lemonde.fr/societe/article/2011/03/31/rendu-accro-au-jeu-et-au-sexe-par-un-medicament-un-nantais-obtient-reparation_1501457_3224.html.

LKAMEL, Nour Eddine. “Civil Liability for Clinical Trials.” Majallat Al-Qada’ Al-Madani 11, no. 21/22 (2020): 109–31.

LKAMEL, Nour Eddine. Civil Liability for Pharmaceutical Product Damage. 1st ed. Dar Al-Afaq Al-Maghribiya Lil-Nashr Wal-Tawzi’a, 2024.

Mischkowski, Dominik, Jennifer Crocker, and Baldwin M. Way. “A Social Analgesic? Acetaminophen (Paracetamol) Reduces Positive Empathy.” Frontiers in Psychology 10 (2019): 538.

Mischkowski, Dominik, Jennifer Crocker, and Baldwin M. Way. “From Painkiller to Empathy Killer: Acetaminophen (Paracetamol) Reduces Empathy for Pain.” Social Cognitive and Affective Neuroscience 11, no. 9 (2016): 1345–53.

Musta’qil Vs Sharikat Taysir Ghaz, No. 2536 (Supreme Council May 28, 2005). https://juriscassation.cspj.ma/upl/2005/1640087433.pdf.

Noah, Lars. “This Is Your Products Liability Restatement on Drugs.” Brooklyn Law Review 74 (2009). https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1316387.

Owen, David G. “Proof of Product Defect.” Ky. Lj 93 (2004): 1.

Owen, G. Owen. Products Liability In a Nutshell. Eighth. West Academic Publishing, 2008.

Phillips, Jerry J. Products Liability in a Nutshell. West Group, 1998.

Powell, Robert E., and M. King Hill Jr. “Proof of a Defect or Defectiveness.” U. Balt. L. Rev. 5 (1975): 77.

Prosser, William L. “The Assault upon the Citadel (Strict Liability to the Consumer).” Yale Lj 69 (1959): 1099.

Radi’an Al-Azzawi, Salem Mohammed. Mas’uliyat Al-Montij Fi Al-Qawanin Al-Madaniyya Wal-Ittifaqiyyat Al-Dawliyya. Dar Al-Thaqafah, 2008.

Rifai, Mohammed Nasr. Al-Darar Ka Asas Lil-Mas’uliyya Al-Madaniyya Fi Al-Mujtama’ Al-Mu’asir. Dar Al-Nahda Al-Arabiya, 1978.

Saad, Nabil Ibrahim. Al-Tatawwur Fi Zil Al-Thabat Fi Masadir Al-Iltizam (Bimunasabat Murur Mi’atayn Sana ’Ala Al-Taqnin Al-Madani Al-Faransi). 1st ed. Dar Al-Jamia’ Al-Jadida, 2005.

Safi, Abdulhaq. Al-Wajiz Fi Al-Qanun Al-Madani, Al-Masadir Ghayr Al-Iradia Lil-Iltizam (Al-Mas’uliyya Al-Madaniyya Wal-Ithra’ Bila Sabab) Dirasat Fi Q.L.A. Wa Fi Al-Qawanin Al-Ukhra. 2nd ed. Published by its author, 2021.

Sey Youssef, Zahya Houria. Al-Mas’uliyya Al-Madaniyya Lil-Montij. Dar Houma, 2009.

Shaheeda, Qada. “Al-Mas’uliyya Al-Madaniyya Lil-Montij – Dirasat Muqarana.” Doctoral Thesis in Private Law, Faculty of Law Abu Bakr Belkaid University, 2004.

Traynor, Roger J. “The Ways and Meanings of Defective Products and Strict Liability.” Tenn. L. Rev. 32 (1964): 363.

Tribunal Administratif de Montreuil, No. 1704392 (Tribunal administratif de Montreuil July 2, 2020). https://montreuil.tribunal-administratif.fr/Media/mediatheque-ta-montreuil/import/1704392.

VINEY, Geneviève. Introduction à la responsabilité. 3rd ed. Alpha, 2009.

Walters, Stephen S. “Products Liability and the Problem of Proof.” Stan. L. Rev. 21 (1968): 1777.

Zaki, Mahmoud Gamal El-Din. Mushkilat Al-Mas’uliyya Al-Madaniyya. Jami’at Al-Qahira, 1978.

Downloads

Published

2026-09-07

Issue

Vol. 9 No. 2 (2026): DECEMBER

Section

Articles

License

Copyright (c) 2026 Nour Eddine LKAMEL, Mohammed SEMNOUN

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution-ShareAlike License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.